240 related articles for article (PubMed ID: 21902544)
41. Knockdown of IGF-IR by Antisense Oligodeoxynucleotide auguments the sensitivity of bladder cancer cells to mitomycin.
Sun HZ; Wu SF; Tu ZH
Acta Pharmacol Sin; 2001 Sep; 22(9):841-6. PubMed ID: 11749868
[TBL] [Abstract][Full Text] [Related]
42. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
Kyou Kwon J; Kim SJ; Hoon Kim J; Mee Lee K; Ho Chang I
Urol Oncol; 2014 Jan; 32(1):51.e27-35. PubMed ID: 24239466
[TBL] [Abstract][Full Text] [Related]
43. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
44. RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice.
Yao J; Da M; Guo T; Duan Y; Zhang Y
Tumour Biol; 2013 Jun; 34(3):1493-501. PubMed ID: 23475632
[TBL] [Abstract][Full Text] [Related]
45. Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q
Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205
[TBL] [Abstract][Full Text] [Related]
46. Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
Ceci C; Tentori L; Atzori MG; Lacal PM; Bonanno E; Scimeca M; Cicconi R; Mattei M; de Martino MG; Vespasiani G; Miano R; Graziani G
Nutrients; 2016 Nov; 8(11):. PubMed ID: 27879653
[TBL] [Abstract][Full Text] [Related]
47. Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
Kunze D; Wuttig D; Fuessel S; Kraemer K; Kotzsch M; Meye A; Grimm MO; Hakenberg OW; Wirth MP
Anticancer Res; 2008; 28(4B):2259-63. PubMed ID: 18751404
[TBL] [Abstract][Full Text] [Related]
48. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
Sun HZ; Wu SF; Tu ZH
Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
[TBL] [Abstract][Full Text] [Related]
49. Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
Kim CJ; Terado T; Tambe Y; Mukaisho KI; Sugihara H; Kawauchi A; Inoue H
Int J Oncol; 2018 Jan; 52(1):231-240. PubMed ID: 29115414
[TBL] [Abstract][Full Text] [Related]
50. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
Noguchi S; Yasui Y; Iwasaki J; Kumazaki M; Yamada N; Naito S; Akao Y
Cancer Lett; 2013 Jan; 328(2):353-61. PubMed ID: 23104321
[TBL] [Abstract][Full Text] [Related]
51. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
52. Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
Chi BJ; Du CL; Fu YF; Zhang YN; Wang RW
Int J Clin Exp Pathol; 2015; 8(10):12533-40. PubMed ID: 26722441
[TBL] [Abstract][Full Text] [Related]
53. Smac/DIABLO promotes mitomycin C-induced apoptosis of bladder cancer T24 cells.
Wang L; Fuqing Z; Zheng L; Tong Q
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):317-8, 328. PubMed ID: 16961280
[TBL] [Abstract][Full Text] [Related]
54. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
55. Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo.
Sun F; Zheng XY; Ye J; Wu TT; Wang Jl; Chen W
Nutr Cancer; 2012; 64(4):599-606. PubMed ID: 22482362
[TBL] [Abstract][Full Text] [Related]
56. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
57. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer.
Lin W; Jiang L; Chen Y; She F; Han S; Zhu J; Zhou L; Tang N; Wang X; Li X
Cancer Lett; 2012 Jan; 314(2):127-36. PubMed ID: 22071224
[TBL] [Abstract][Full Text] [Related]
58. The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines.
van der Heijden AG; Jansen CF; Verhaegh G; O'donnell MA; Schalken JA; Witjes JA
Eur Urol; 2004 Nov; 46(5):670-4. PubMed ID: 15474281
[TBL] [Abstract][Full Text] [Related]
59. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Nie L; Gui Y; Cai Z
Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
[TBL] [Abstract][Full Text] [Related]
60. [Effects of gene Livin transfection affect on the apoptosis in bladder carcinoma cells].
Liu XK; Liu HB; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):853-5. PubMed ID: 18756993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]